Perna S, Guido D, Bologna C et al (2016) Liraglutide and obesity in elderly: efficacy in fat loss and safety in order to prevent sarcopenia
With personalized insights and tailored recommendations, AI helps patients stay engaged, optimize their treatment, and achieve better outcomes
Recently, the newly developed drug tirzepatide, which targets both the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, was introduced to the market to treat type 2 diabetes and obesity in 2022 and 2023, respectively (Table 1)
If the result of Larkin limits how much PBMs can manage GLP-1 utilization, many plans may lose key tools they currently rely on
Case Study Reflection Risk Factors for DVT Marias risk factors for developing deep vein thrombosis (DVT) include her age (over 65), obesity (BMI 32), history of hypertension and diabetes, and atrial fibrillation
The most common side effects of Male Excels Testosterone Lipoderm Cream include increased prostate-specific antigen (a test used to screen for prostate cancer), mood swings, high blood pressure, increased red blood cell count, acne, and skin irritation where the gel is applied
